BCCIP antibody (PE)
Quick Overview for BCCIP antibody (PE) (ABIN2170552)
Target
See all BCCIP AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human BCCIP/TOK1
-
Isotype
- IgG
-
-
-
-
Application Notes
-
FCM: (1:20-100)
Optimal working dilution should be determined by the investigator. -
Comment
-
Exitation/Emission: 480,565nm/578nm
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at 4 °C for 12 months.
-
-
- BCCIP (BRCA2 and CDKN1A Interacting Protein (BCCIP))
-
Alternative Name
- Bccip
-
Background
-
FunctionMay promote cell cycle arrest by enhancing the inhibition of CDK2 activity by CDKN1A. May be required for repair of DNA damage by homologous recombination in conjunction with BRCA2. May not be involved in non-homologous end joining.
Synonyms: bccip, BCCIP_HUMAN, BCCIPalpha, BCCIPbeta, BRCA2 and CDKN1A interacting protein, BRCA2 and CDKN1A-interacting protein, BRCA2 and Cip1/p21 interacting protein, Cdk inhibitor p21 binding protein, P21 and CDK associated protein 1, P21- and CDK-associated protein 1, Protein TOK-1, Protein TOK1, TOK 1, TOK 1alpha, TOK 1beta, TOK1. -
Gene ID
- 56647
Target
-